Literature DB >> 21345815

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.

Raphaèle Seror1, Philippe Ravaud, Xavier Mariette, Hendrika Bootsma, Elke Theander, Arne Hansen, Manel Ramos-Casals, Thomas Dörner, Stefano Bombardieri, Eric Hachulla, Johan G Brun, Aike A Kruize, Sonja Praprotnik, Matija Tomsic, Jacques-Eric Gottenberg, Valerie Devauchelle, Salvatore Devita, Cristina Vollenweider, Thomas Mandl, Athanasios Tzioufas, Steven Carsons, Alain Saraux, Nurhan Sutcliffe, Claudio Vitali, Simon J Bowman.   

Abstract

OBJECTIVES: To develop a score for assessment of patients' symptoms in primary Sjögren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI).
METHODS: Dryness, pain, somatic and mental fatigue were identified as the main symptoms of patients with primary SS, in studies developing the Profile of Fatigue and Discomfort (PROFAD) and Sicca Symptoms Inventory (SSI). It was suspected that a single 0-10 numerical scale for each domain was sufficient to assess these symptoms. These four scales were gathered to form the ESSPRI. 230 patients, from 12 countries completed the ESSPRI, SSI and PROFAD questionnaires and a 0-10 patient global assessment (PGA). Correlations between each symptom and PGA were obtained. Multiple regression modelling, using PGA as 'gold standard' was used to select domains and estimate their weights.
RESULTS: PGA had good correlation with dryness, limb pain, fatigue and mental fatigue (r=0.49-0.59, all p<0.0001), but correlated less well with individual dryness features. In multivariate analysis, dryness, limb pain and fatigue, but not mental fatigue, were significantly associated with PGA; weights derived from the regression were identical for these three domains. Thus, ESSPRI was redefined as the mean of the three scales: dryness, limb pain and fatigue. Lastly, ESSPRI significantly correlated with PGA (r=0.70), PROFAD (r=0.73) and SSI (r=0.66).
CONCLUSION: ESSPRI is a very simple index designed to measure patients' symptoms in primary SS. It has good construct validity and is well correlated with SSI and PROFAD. ESSPRI should now be validated for use as an outcome measure in clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21345815     DOI: 10.1136/ard.2010.143743

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  111 in total

Review 1.  Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó-Almirall; Xavier Bosch; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2012-05-01       Impact factor: 20.543

2.  Swallowing Disorders in Sjögren's Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life.

Authors:  Jenny L Pierce; Kristine Tanner; Ray M Merrill; Karla L Miller; Katherine A Kendall; Nelson Roy
Journal:  Dysphagia       Date:  2015-10-19       Impact factor: 3.438

3.  Biomarkers: new biomarker for Sjögren's syndrome--time to treat patients.

Authors:  Frans G M Kroese; Hendrika Bootsma
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

4.  Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?

Authors:  Gintaras Sudzius; Diana Mieliauskaite; Almantas Siaurys; Rita Viliene; Irena Butrimiene; Dainius Characiejus; Irena Dumalakiene
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

5.  Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.

Authors:  Maike Jülich; Anna-Maria Kanne; Bettina Sehnert; Stephan Budweiser; Reinhard E Voll; Florian Kollert
Journal:  Clin Rheumatol       Date:  2018-06-01       Impact factor: 2.980

Review 6.  [Sjögren's syndrome].

Authors:  Torsten Witte
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

7.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

8.  Increased risks of psychiatric disorders in patients with primary Sjögren's syndrome-a secondary cohort analysis of nationwide, population-based health claim data.

Authors:  Min-Chih Hsieh; Chia-Wen Hsu; Ming-Chi Lu; Malcolm Koo
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

9.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12

10.  Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.

Authors:  Samira Tatiyama Miyamoto; Valéria Valim; Luciana Carletti; Wan-Fai Ng; Anselmo José Perez; Dennis William Lendrem; Michael Trennel; Raquel Altoé Giovelli; Laiza Hombre Dias; Érica Vieira Serrano; Alice Mendonça Subtil; Vanessa Cândido Abreu; Jamil Natour
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.